Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Rodrigues PM, Afonso MB, Simão AL, Islam T, Gaspar MM, O'Rourke CJ, Lewinska M, Andersen JB, Arretxe E, Alonso C, Santos-Laso Á, Izquierdo-Sanchez L, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Prip-Buus C, Banales JM, Rodrigues CMP, Castro RE. Rodrigues PM, et al. Among authors: prip buus c. Liver Int. 2023 Oct;43(10):2256-2274. doi: 10.1111/liv.15682. Epub 2023 Aug 3. Liver Int. 2023. PMID: 37534739
UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling.
Sancerni T, Renoult O, Luby A, Caradeuc C, Lenoir V, Croyal M, Ransy C, Aguilar E, Postic C, Bertho G, Dentin R, Prip-Buus C, Pecqueur C, Alves-Guerra MC. Sancerni T, et al. Among authors: prip buus c. Front Immunol. 2022 Oct 6;13:960226. doi: 10.3389/fimmu.2022.960226. eCollection 2022. Front Immunol. 2022. PMID: 36275699 Free PMC article.
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease.
Afonso MB, Islam T, Magusto J, Amorim R, Lenoir V, Simões RF, Teixeira J, Silva LC, Wendum D, Jéru I, Vigouroux C, Castro RE, Oliveira PJ, Prip-Buus C, Ratziu V, Gautheron J, Rodrigues CMP. Afonso MB, et al. Among authors: prip buus c. Hepatology. 2023 Apr 1;77(4):1319-1334. doi: 10.1002/hep.32756. Epub 2022 Oct 11. Hepatology. 2023. PMID: 36029129 Free PMC article.
Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.
Gautheron J, Lima L, Akinci B, Zammouri J, Auclair M, Ucar SK, Ozen S, Altay C, Bax BE, Nemazanyy I, Lenoir V, Prip-Buus C, Acquaviva-Bourdain C, Lascols O, Fève B, Vigouroux C, Noel E, Jéru I. Gautheron J, et al. Among authors: prip buus c. BMC Med. 2022 Mar 28;20(1):95. doi: 10.1186/s12916-022-02296-2. BMC Med. 2022. PMID: 35341481 Free PMC article.
Loss and gain of function of Grp75 or mitofusin 2 distinctly alter cholesterol metabolism, but all promote triglyceride accumulation in hepatocytes.
Bassot A, Prip-Buus C, Alves A, Berdeaux O, Perrier J, Lenoir V, Ji-Cao J, Berger MA, Loizon E, Cabaret S, Panthu B, Rieusset J, Morio B. Bassot A, et al. Among authors: prip buus c. Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Dec;1866(12):159030. doi: 10.1016/j.bbalip.2021.159030. Epub 2021 Aug 20. Biochim Biophys Acta Mol Cell Biol Lipids. 2021. PMID: 34419589
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A, Aoudjehane L, Ratziu V, Islam T, Afonso MB, Conti F, Mestiri T, Lagouge M, Foufelle F, Ballenghien F, Ledent T, Moldes M, Cadoret A, Fouassier L, Delaunay JL, Aït-Slimane T, Courtois G, Fève B, Scatton O, Prip-Buus C, Rodrigues CMP, Housset C, Gautheron J. Majdi A, et al. Among authors: prip buus c. J Hepatol. 2020 Apr;72(4):627-635. doi: 10.1016/j.jhep.2019.11.008. Epub 2019 Nov 21. J Hepatol. 2020. PMID: 31760070
68 results